Sam Santhosh

Sam Santhosh is the Founder and CEO of MedGenome, an AI-driven healthcare company based in India that leverages artificial intelligence and genomics to advance precision medicine and diagnostics. Under his leadership, MedGenome has established itself as a significant player in the intersection of genomic analysis and healthcare intelligence, serving clinicians and patients across India and internationally.

Santhosh built MedGenome with a focus on making genomic insights accessible and actionable within clinical workflows. The company operates at the convergence of healthcare, genomics, and AI—domains that require deep technical expertise combined with an understanding of clinical and regulatory requirements. His approach has centered on developing practical applications that translate genetic data into meaningful diagnostic and treatment recommendations.

MedGenome has grown to Series C funding stage with over $50 million raised to date, demonstrating investor confidence in its business model and technology platform. The company has expanded its reach across multiple healthcare segments, including cancer diagnostics, genetic testing, and personalized medicine. Its work reflects a commitment to addressing diagnostic gaps in the Indian healthcare system while building solutions that can scale across emerging markets where genomic services remain limited.